Marine organisms have developed unique metabolic and physiological capabilities that ensure survival in diverse habitats and offer the potential to produce metabolites that would not be observed from terrestrial organisms. The basic biology and biochemistry of marine organisms is generally very poorly understood; presenting a huge challenge and a huge opportunity for the identification of new drugs. Historically, terrestrial natural products have been a premier source for commercially successful drugs. Recently, however, there have been dimishing returns from attemps to further exploit terrestrial sources. GlycoMar believes that the production of new, biologically active compounds from marine organisms has the potential to exceed that previously developed from terrestrial sources, and published trends support this belief.
GlycoMar specialises in the isolation and purification of products from marine organisms, excluding mammals. Species are selected for their potential to provide novel compounds, and for their availability and future sustainability. GlycoMar is the only company dedicated to the isolation and characterisation of novel glycobiology products from marine organisms.
